18016289. HYDROISOQUINOLINE OR HYDRONAPHTHYRIDINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE simplified abstract (Hoffmann-La Roche Inc.)
Contents
HYDROISOQUINOLINE OR HYDRONAPHTHYRIDINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE
Organization Name
Inventor(s)
Xiaoqing Wang of Shanghai (CN)
HYDROISOQUINOLINE OR HYDRONAPHTHYRIDINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE - A simplified explanation of the abstract
This abstract first appeared for US patent application 18016289 titled 'HYDROISOQUINOLINE OR HYDRONAPHTHYRIDINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE
The present invention relates to compounds of formula (I).
- Simplified Explanation:
The patent application discusses compounds of a specific formula.
- Key Features and Innovation:
- The compounds are of formula (I). - The invention likely involves novel chemical structures or compositions.
- Potential Applications:
- Pharmaceutical industry for drug development. - Chemical industry for new materials or products.
- Problems Solved:
- Providing new compounds for potential applications. - Addressing the need for innovative chemical structures.
- Benefits:
- Potential for new drug discoveries. - Advancements in material science.
- Commercial Applications:
- Drug development for pharmaceutical companies. - Potential licensing opportunities for chemical companies.
- Prior Art:
- Readers can explore databases like Google Patents or the USPTO for prior art related to similar compounds or formulas.
- Frequently Updated Research:
- Stay updated on new developments in the field of chemistry or pharmaceuticals related to compounds of formula (I).
Questions about compounds of formula (I): 1. What are the potential challenges in synthesizing compounds of formula (I)? 2. How do compounds of formula (I) compare to existing chemical structures in terms of stability and reactivity?
Original Abstract Submitted
The present invention relates to compounds of formula (I),
